Provided by Tiger Trade Technology Pte. Ltd.

Vermillion

4.00
0.0000
Volume:- -
Turnover:- -
Market Cap:389.51M
PE:-23.63
High:4.00
Open:4.00
Low:4.00
Close:4.00
52wk High:5.78
52wk Low:0.3506
Shares:97.38M
Float Shares:47.10M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1692
EPS(LYR):-0.1760
ROE:-340.69%
ROA:-103.18%
PB:73.47
PE(LYR):-22.73

Loading ...

Company Profile

Company Name:
Vermillion
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.